Corbus Pharmaceuticals Holdings Inc reports results for the quarter ended in March - Earnings Summary

Corbus Pharmaceuticals Holdings

09/05/2023 14:42

* Corbus Pharmaceuticals Holdings Inc  CRBP.OQ  reported a
quarterly adjusted loss of $4.24​​ per share for the quarter
ended in March. The lone analyst forecast for the quarter was
for a loss of $4.09 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Corbus Pharmaceuticals Holdings Inc's reported EPS for the
quarter was a loss of $4.24​.
    * The mean earnings estimate of analysts had fallen by
about 94.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Corbus Pharmaceuticals Holdings Inc shares had risen
by 39.3%
this quarter and gained 205.6% so far this year.
    * The company reported a quarterly loss of $17.74 million.
    * Wall Street's median 12-month price target for Corbus
Pharmaceuticals Holdings Inc is $120.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 01:42 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -4.09          -4.24          Missed
 Dec. 31 2022      -2.10          -2.61          Missed
 Sep. 30 2022      -1.65          -2.10          Missed
 Jun. 30 2022      -1.80          -3.30          Missed